Literature DB >> 9103439

Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.

M Vergelli1, B Hemmer, M Kalbus, A B Vogt, N Ling, P Conlon, J E Coligan, H McFarland, R Martin.   

Abstract

In this report, we demonstrate for autoreactive T cell clones that single amino acid modifications of the antigenic ligand can result in not only abrogated, decreased, or unmodified, but also increased, T cell responsiveness (superagonist ligands). We further studied the effects of combinations of multiple substitutions with different effects in single peptides. Experiments with peptides carrying multiple amino acid exchanges revealed that the final outcome of TCR ligation by a given ligand is the integration of negative, neutral, and positive effects of each single residue. In addition, the introduction of superagonist substitutions together with nonconservative modifications of primary and secondary TCR contacts resulted in stimulatory ligands. These findings indicate that: 1) the specificity of a single TCR is highly degenerate; 2) ligands exist for autoreactive T cells that have higher agonist activity than the autoantigen itself; 3) the rules to search for cross-reactive epitopes in autoimmunity should take into account that amino acids at certain positions within an antigenic peptide may exert superagonist activity and compensate for the negative effects of residues at other positions that would otherwise not be tolerated.

Mesh:

Substances:

Year:  1997        PMID: 9103439

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  T cells, cytokines, and autoantigens in multiple sclerosis.

Authors:  B Gran; A Rostami
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

2.  Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.

Authors:  L B Nicholson; H Waldner; A M Carrizosa; A Sette; M Collins; V K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.

Authors:  Jacqueline A Quandt; Jaebong Huh; Mirza Baig; Karen Yao; Naoko Ito; Mark Bryant; Kazuyuki Kawamura; Clemencia Pinilla; Henry F McFarland; Roland Martin; Kouichi Ito
Journal:  J Immunol       Date:  2012-08-10       Impact factor: 5.422

4.  Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.

Authors:  B Hemmer; B T Fleckenstein; M Vergelli; G Jung; H McFarland; R Martin; K H Wiesmüller
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

5.  Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions.

Authors:  Raquel Planas; Imke Metz; Yaneth Ortiz; Nuria Vilarrasa; Ilijas Jelčić; Gabriela Salinas-Riester; Christoph Heesen; Wolfgang Brück; Roland Martin; Mireia Sospedra
Journal:  Ann Clin Transl Neurol       Date:  2015-06-08       Impact factor: 4.511

Review 6.  Activation of autoreactive T cells by peptides from human pathogens.

Authors:  S Hausmann; K W Wucherpfennig
Journal:  Curr Opin Immunol       Date:  1997-12       Impact factor: 7.486

7.  In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis.

Authors:  R L Ufret-Vincenty; L Quigley; N Tresser; S H Pak; A Gado; S Hausmann; K W Wucherpfennig; S Brocke
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

Review 8.  Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.

Authors:  B Gran; B Hemmer; M Vergelli; H F McFarland; R Martin
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

9.  HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.

Authors:  Jian Wang; Ivan Jelcic; Lena Mühlenbruch; Veronika Haunerdinger; Nora C Toussaint; Yingdong Zhao; Carolina Cruciani; Wolfgang Faigle; Reza Naghavian; Magdalena Foege; Thomas M C Binder; Thomas Eiermann; Lennart Opitz; Laura Fuentes-Font; Richard Reynolds; William W Kwok; Julie T Nguyen; Jar-How Lee; Andreas Lutterotti; Christian Münz; Hans-Georg Rammensee; Mathias Hauri-Hohl; Mireia Sospedra; Stefan Stevanovic; Roland Martin
Journal:  Cell       Date:  2020-10-21       Impact factor: 41.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.